Acrivon Therapeutics stock price
NASDAQ:ACRV · Nasdaq · Healthcare · sector #16Acrivon Therapeutics's chart data is dated 2026-10-21. Recorded technical signals: Mean reversion. There are 4 published signal records.
Acrivon Therapeutics last closed at $1.82 (+1.67%) on 2026-10-21. Signals today: Mean reversion. Listed on Nasdaq. Trailing 12 months PER is -1.0×. Its overall grade ranks 457 of 727 stocks in Healthcare.
About this company
Acrivon Therapeutics last closed at $1.82 (+1.67%) on 2026-10-21. Signals today: Mean reversion. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C+ · 457/727
Valuation grade B-
Related stocks
- AstraZenecaCompetitor
- Merck & CoCompetitor
- Bristol Myers SquibbCompetitor
About Acrivon Therapeutics
- What technical signals does Acrivon Therapeutics (ACRV) have?
- Acrivon Therapeutics current technical signals: Mean reversion.
- Is Acrivon Therapeutics a cup-and-handle pattern?
- No. Acrivon Therapeutics has no valid Cup signal right now.
- What published figures are available for Acrivon Therapeutics?
- Market cap: $57.43M. Trailing 12 months PER: -1.0×. Latest quarter PBR: 0.88×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Acrivon Therapeutics, or open the plan table on the main site.
Ask Q about Acrivon Therapeutics.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.